David Rodman Malcom Insider Trading Activity

Corporate InsiderChief Medical Officer · CIK 1672659

35

Total trades

$14.1M

Total volume

May 18, 2026

Last activity

MLYS

Mineralys Therapeutics, Inc.

David Rodman Malcom has been net-selling over the last 12 months with 0 purchases and 33 sales across 1 company.

MLYS is the most-traded position with 33 trades. The largest single transaction was a sale of MLYS for $4.8M on Jan 5, 2026.

Performance Scorecard

Forward stock performance after each transaction by David Rodman Malcom. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days-0.2%74%35
90 days-11.4%81%31
120 days-13.0%70%27

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

MLYS · Mineralys Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when David Rodman Malcom bought and sold MLYS.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
May 18, 2026
MLYSSell417$27.55$11K−0.7%Chief Medical Officer
May 13, 2026
MLYSSell14,056$28.58$402K−18.1%Chief Medical Officer
May 12, 2026
MLYSSell6,348$29.36$186K−8.3%Chief Medical Officer
May 11, 2026
MLYSSell2,171$29.71$65K−3.0%Chief Medical Officer
Apr 17, 2026
MLYSSell416$31.33$13K−0.6%Chief Medical Officer
Apr 15, 2026
MLYSSell6,348$27.66$176K−8.3%Chief Medical Officer
Apr 13, 2026
MLYSSell14,058$26.54$373K−15.6%Chief Medical Officer
Apr 9, 2026
MLYSSell2,170$27.38$59K−2.8%Chief Medical Officer
Mar 17, 2026
MLYSSell417$25.65$11K−0.5%Chief Medical Officer
Mar 13, 2026
MLYSSell10,726$25.91$278K−11.9%Chief Medical Officer
Mar 13, 2026
MLYSSell3,079$27.37$84K−3.9%Chief Medical Officer
Mar 13, 2026
MLYSSell253$27.82$7K−0.3%Chief Medical Officer
Mar 12, 2026
MLYSSell6,348$27.37$174K−7.1%Chief Medical Officer
Mar 9, 2026
MLYSSell2,171$26.84$58K−2.6%Chief Medical Officer
Feb 17, 2026
MLYSSell417$27.59$12K−0.9%Chief Medical Officer
Feb 13, 2026
MLYSSell3,541$27.33$97K−6.6%Chief Medical Officer
Feb 13, 2026
MLYSSell4,166$27.33$114K−7.6%Chief Medical Officer
Feb 13, 2026
MLYSSell6,348$27.58$175K−12.6%Chief Medical Officer
Feb 12, 2026
MLYSSell5,828$28.94$169K−10.3%Chief Medical Officer
Feb 12, 2026
MLYSSell521$29.64$15K−1.0%Chief Medical Officer
Feb 9, 2026
MLYSSell2,171$30.21$66K−4.1%Chief Medical Officer
Jan 20, 2026
MLYSSell416$32.10$13K−0.8%Chief Medical Officer
Jan 14, 2026
MLYSSell11,367$32.61$371K−18.4%Chief Medical Officer
Jan 13, 2026
MLYSSell7,709$32.75$252K−11.1%Chief Medical Officer
Jan 12, 2026
MLYSSell6,348$32.32$205K−9.3%Chief Medical Officer
Jan 9, 2026
MLYSSell2,170$33.27$72K−3.4%Chief Medical Officer
Jan 5, 2026
MLYSSell139,245$34.83$4.8M−54.7%Chief Medical Officer
Jan 5, 2026
MLYSSell53,470$35.53$1.9M−46.4%Chief Medical Officer
Jan 2, 2026
MLYSSell70,037$35.87$2.5M−50.3%Chief Medical Officer
Oct 15, 2025
MLYSSell10,369$43.01$446K−12.7%Chief Medical Officer
Sep 15, 2025
MLYSSell9,302$35.90$334K−10.0%Chief Medical Officer
Sep 15, 2025
MLYSSell2,065$36.47$75K−2.5%Chief Medical Officer
Aug 13, 2025
MLYSSell11,365$12.93$147K−10.9%Chief Medical Officer
Jul 14, 2025
MLYSSell11,366$14.59$166K−10.4%Chief Medical Officer
Jun 13, 2025
MLYSSell11,366$14.60$166K−10.1%Chief Medical Officer

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
MLYSMineralys Therapeutics, Inc.35$14.1M

Other insiders at Mineralys Therapeutics, Inc.

5 other tracked filers at MLYS.